A-803467
(Synonyms: 5-(4-氯苯基)-N-(3,5-二甲氧基苯基)-2-呋喃甲酰胺) 目录号 : GC15701
An inhibitor of Nav1.8 channels
Cas No.:944261-79-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cell experiment [1]: | |
|
Cell lines |
Rat dorsal root ganglion (DRG) neurons and HEK-293 cells expressing human Nav1.8 sodium channels |
|
Preparation method |
The solubility of this compound in DMSO is > 13.95 mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below - 20 °C for several months. |
|
Reacting condition |
0 ~ 100 μM |
|
Applications |
A-803467 at the dose of 100 nM significantly blocks recombinant human and native rat Nav1.8 currents. In rat DRG neurons, A-803467 concentration-dependently blocked tetrodotoxin-resistant (TTX-R) current at the potential of -40 mV, with the IC50 value of 140 nM. |
| Animal experiment [1]: | |
|
Animal models |
Spinal nerve ligated rats |
|
Dosage form |
20 mg/kg; i.v. |
|
Applications |
In spinal nerve ligated rats, A-803467 markedly reduced spontaneous and von Frey hair evoked firing of spinal dorsal horn wide dynamic range neurons by 66% and 53%, respectively, which implied that systemic administration of A-803467 altered the activity of spinal sensory neurons. In addition, these effects of A-803467 were dose-dependent. |
|
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
|
References: [1]. Jarvis M F, Honore P, Shieh C C, et al. A-803467, a potent and selective Nav1. 8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proceedings of the National Academy of Sciences, 2007, 104(20): 8520-8525. | |
A-803467 is a potent and selective blocker of Nav1.8 sodium channel with IC50 value of 8nM [1].
A-803467 is a sodium channel blocker with high affinity and selectivity. It blocks the human Nav1.8 channels with IC50 value of 79nM. It also blocks the recombinant rat Nav1.8 channels with IC50 value of 45nM when the holding potential is -40mV. A-803467 is highly selective against Nav1.8 since the inhibition of Nav1.8 is 300- to 1000-fold more potent than of NaV1.2, NaV1.3, NaV1.5, and NaV1.7. It is found that A-803467 effectively suppresses the evoked and spontaneous action potential firing in DRG neurons in which TTX-R currents play a remarkable role. Furthermore, the selective blockade of Nav1.8 channels results in a significant reduction in nociceptive sensitivity. A-803467 potently attenuates mechanical allodynia in models of neuropathic pain. It also potently reduces thermal hyperalgesia in the CFA model of inflammatory pain [1].
References:
[1] Jarvis M F, Honore P, Shieh C C, et al. A-803467, a potent and selective Nav1. 8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proceedings of the National Academy of Sciences, 2007, 104(20): 8520-8525.
| Cas No. | 944261-79-4 | SDF | |
| 别名 | 5-(4-氯苯基)-N-(3,5-二甲氧基苯基)-2-呋喃甲酰胺 | ||
| 化学名 | 5-(4-chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | ||
| Canonical SMILES | COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(C=C3)Cl)OC | ||
| 分子式 | C19H16ClNO4 | 分子量 | 357.79 |
| 溶解度 | ≥ 13.95mg/mL in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.7949 mL | 13.9747 mL | 27.9494 mL |
| 5 mM | 0.559 mL | 2.7949 mL | 5.5899 mL |
| 10 mM | 0.2795 mL | 1.3975 mL | 2.7949 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。